Is this you? Create Your Porfile
Avatar

Douglas S. Daniels

Novartis

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Douglas S. Daniels is active.

Explore More

Publication

Featured researches published by Douglas S. Daniels.

Archive | 2012

Dual function proteins for treating metabolic disorders

Brian R. Boettcher; Shari L. Caplan; Susan E. Cellitti; Douglas S. Daniels; Norio Hamamatsu; Bernhard H. Geierstanger; Stuart Licht; Andreas Loew; Stephen Craig Weldon

Archive | 2012

Fusion proteins for treating metabolic disorders

Brian R. Boettcher; Shari L. Caplan; Douglas S. Daniels; Norio Hamamatsu; Stuart Licht; Stephen Craig Weldon

Archive | 2011

Methods of treating FGF21-associated disorders

Brian R. Boettcher; Shari L. Caplan; Douglas S. Daniels; Bernhard H. Geierstanger; Norio Hamamatsu; Stuart Licht; Andreas Loew; Stephen Craig Weldon

Archive | 2012

Fibroblast growth factor-21-Fc fusion proteins

Brian R. Boettcher; Shari L. Caplan; Douglas S. Daniels; Norio Hamamatsu; Stuart Licht; Stephen Craig Weldon

Archive | 2011

Fibroblast growth factor 21 mutations

Brian R. Boettcher; Shari L. Caplan; Douglas S. Daniels; Bernhard H. Geierstanger; Norio Hamamatsu; Stuart Licht; Andreas Loew; Stephen Craig Weldon

Archive | 2015

Methods of treating metabolic disorders with an FGF21 variant

Brian R. Boettcher; Shari L. Caplan; Douglas S. Daniels; Norio Hamamatsu; Stuart Licht; Stephen Craig Weldon

Archive | 2012

Dual function fibroblast growth factor 21 proteins

Brian R. Boettcher; Shari L. Caplan; Douglas S. Daniels; Norio Hamamatsu; Stuart Licht; Stephen Craig Weldon; Susan E. Cellitti; Bernhard Hubert Geierstranger; Andreas Loew

Archive | 2017

proteínas de função dual para o tratamento de distúrbios metabólicos

Andreas Loew; Bernhard Hubert Geierstanger; Brian R. Boettcher; Douglas S. Daniels; Norio Hamamatsu; Shari L. Caplan; Stephen Craig Weldon; Stuart Licht; Susan E. Cellitti

Archive | 2017

proteínas de fusão para o tratamento de distúrbios metabólicos

Brian R. Boettcher; Douglas S. Daniels; Norio Hamamatsu; Shari L. Caplan; Stephen Craig Weldon; Stuart Licht

Archive | 2014

Variante polipeptidica de fgf21; multimero que la comprende; composicion farmaceutica que la comprende; y su uso para tratar uno o mas trastornos asociados a fgf21.

Andreas Loew; Brian R. Boettcher; Shari L. Caplan; Douglas S. Daniels; Bernhard Hubert Geierstanger; Norio Hamamatsu; Stuart Licht; Stephen Craig Weldon

Explore More

Collaboration

Dive into the Douglas S. Daniels's collaboration.

Top Co-Authors
Avatar

Brian R. Boettcher

Novartis

View shared research outputs
Top Co-Authors
Avatar

Shari L. Caplan

Novartis

View shared research outputs
Top Co-Authors
Avatar

Stephen Craig Weldon

Novartis

View shared research outputs
Top Co-Authors
Avatar

Stuart Licht

Novartis

View shared research outputs
Top Co-Authors
Avatar

Norio Hamamatsu

Novartis

View shared research outputs
Top Co-Authors
Avatar

Andreas Loew

Novartis

View shared research outputs
Top Co-Authors
Avatar

Bernhard H. Geierstanger

Genomics Institute of the Novartis Research Foundation

View shared research outputs
Top Co-Authors
Avatar

Susan E. Cellitti

Genomics Institute of the Novartis Research Foundation

View shared research outputs
Top Co-Authors
Avatar

Susan E. Cellitti

Genomics Institute of the Novartis Research Foundation

View shared research outputs
Top Co-Authors
Avatar

Bernhard Hubert Geierstranger

Novartis

View shared research outputs
Explore More
Researchain Logo
Decentralizing Knowledge